ALZN Stock Analysis: Buy, Sell, or Hold?
ALZN - Alzamend Neuro, Inc. Common Stock
$1.55
-0.01 (-0.64%)
▼
5d:
-1.9%
30d:
+16.54%
90d:
+37.17%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Sep 09, 2026
14d
Get Alerted When ALZN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ALZN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ALZN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ALZN is currently trading at $1.55, which is considered extended relative to its 30-day fair value range of $1.29 to $1.52.
Technical Outlook: Technically, ALZN is in a strong uptrend. Immediate support is located at $1.41, while resistance sits at $1.67.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.00 (+1577.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALZN is in a strong uptrend. Immediate support is located at $1.41, while resistance sits at $1.67.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $26.00 (+1577.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.29 -
$1.52
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1577.4% below Wall St target ($26.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.29 -
$1.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.41
Resistance Level
$1.67
Current Trend
Strong Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.60
Wall Street Target
$26.00
(+1577.4%)
Share & Embed Analysis
Last updated: August 24, 2026 11:56 PM ET
Data refreshes hourly during market hours. Next update: 12:56 AM
Data refreshes hourly during market hours. Next update: 12:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALZN showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Milton C Ault III
BUY
108388 shares
2026-04-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 39 SELL |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 46 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 46 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 68 BUY |
